Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice
- PMID: 17229843
- PMCID: PMC1773057
- DOI: 10.1073/pnas.0610057104
Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice
Abstract
Type 1 diabetes (T1D) is caused by the destruction of insulin-producing islet beta cells. CD8 T cells are prevalent in the islets of T1D patients and are the major effectors of beta cell destruction in nonobese diabetic (NOD) mice. In addition to their critical involvement in the late stages of diabetes, CD8 T cells are implicated in the initiation of disease. NOD mice, in which the beta2-microglobulin gene has been inactivated by gene targeting (NOD.beta2M-/-), have a deficiency in CD8 T cells and do not develop insulitis, which suggests that CD8 T cells are required for the initiation of T1D. However, neither in humans nor in NOD mice have the immunological requirements for diabetogenic CD8 T cells been precisely defined. In particular, it is not known in which cell type MHC class I expression is required for recruitment and activation of CD8 T cells. Here we have generated transgenic NOD mice, which lack MHC class I on mature professional antigen-presenting cells (pAPCs). These "class I APC-bald" mice developed periislet insulitis but not invasive intraislet insulitis, and they never became diabetic. Recruitment to the islet milieu does not therefore require cognate interaction between CD8 T cells and MHC class I on mature pAPCs. Conversely, such an interaction is critically essential to allow the crucial shift from periislet insulitis to invasive insulitis. Importantly, our findings demonstrate unequivocally that CD8 T cells cannot be primed to become diabetogenic by islet beta cells alone.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.J Immunol. 1996 Oct 15;157(8):3688-93. J Immunol. 1996. PMID: 8871671
-
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.J Immunol. 1999 Jul 15;163(2):743-50. J Immunol. 1999. PMID: 10395666
-
The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.Immunol Rev. 2005 Apr;204:250-63. doi: 10.1111/j.0105-2896.2005.00244.x. Immunol Rev. 2005. PMID: 15790363 Review.
-
CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.Eur J Immunol. 2009 Oct;39(10):2716-24. doi: 10.1002/eji.200939408. Eur J Immunol. 2009. PMID: 19658094
-
CD8+ T cells in type 1 diabetes.Adv Immunol. 2008;100:79-124. doi: 10.1016/S0065-2776(08)00804-3. Adv Immunol. 2008. PMID: 19111164 Review.
Cited by
-
Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells.Front Endocrinol (Lausanne). 2021 Aug 17;12:716692. doi: 10.3389/fendo.2021.716692. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34484126 Free PMC article. Review.
-
HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation.Autoimmune Dis. 2012;2012:745962. doi: 10.1155/2012/745962. Epub 2012 Sep 25. Autoimmune Dis. 2012. PMID: 23050124 Free PMC article.
-
Antigen presentation events in autoimmune diabetes.Curr Opin Immunol. 2012 Feb;24(1):119-28. doi: 10.1016/j.coi.2011.11.005. Epub 2011 Dec 15. Curr Opin Immunol. 2012. PMID: 22178549 Free PMC article. Review.
-
Autoreactive T cells in type 1 diabetes.J Clin Invest. 2017 Aug 1;127(8):2881-2891. doi: 10.1172/JCI94549. Epub 2017 Aug 1. J Clin Invest. 2017. PMID: 28762987 Free PMC article. Review.
-
Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.Front Immunol. 2019 Oct 29;10:2429. doi: 10.3389/fimmu.2019.02429. eCollection 2019. Front Immunol. 2019. PMID: 31736937 Free PMC article. Review.
References
-
- Allison J, Thomas HE, Catterall T, Kay TW, Strasser A. J Immunol. 2005;175:293–301. - PubMed
-
- Katz J, Benoist C, Mathis D. Eur J Immunol. 1993;23:3358–3360. - PubMed
-
- Christianson SW, Shultz LD, Leiter EH. Diabetes. 1993;42:44–55. - PubMed
-
- Serreze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD. J Immunol. 1997;158:3978–3986. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials